With over 15 years track record of successful manufacturing and distribution of pharmaceutical products for local and regional customers, KSP is undergoing the next stage of its impressive journey. Following the recent acquisition of a majority stake in KSP by a large local conglomerate, KSP now has the financial backing and investor support to continue its growth. This investment is both in manufacturing lines, manufacturing buildings, acquisitions and partnerships to develop the product and portfolio range, from its current level of over 120 products, to enable the provision of a wider and broader range of high-quality medicines, throughout the Middle-East and further afield.

our website